LUIS ANDRÉS
GONZÁLEZ BAYÓN

Profesor titular de universidad

Foto de LUIS ANDRÉS

Foto de University of Texas MD Anderson Cancer Center

University of Texas MD Anderson Cancer Center

Houston, Estados Unidos

Publikationen in Zusammenarbeit mit Forschern von University of Texas MD Anderson Cancer Center (4)

2022

GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases
BMC Cancer, Vol. 22, Núm. 1

2020

Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP)
Clinical and Translational Oncology, Vol. 22, Núm. 1, pp. 130-136

2017

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?
Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1388-1392

2016

Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study
Surgical Oncology, Vol. 25, Núm. 2, pp. 111-116